Drug intelligence / Profile preview

TraMag

Development stage
Unknown
Lead developer
Orphinic Scientific
Modality
Small Molecules
Administration
Oral
01

Overview

TraMag (TM) is an oral small molecule combination therapy developed by Orphinic Scientific, consisting of the opioid analgesic tramadol and magnesium. It is primarily indicated for the treatment of pain, specifically in the context of osteoarthritis. Tramadol acts as a mu-opioid receptor agonist and a serotonin-norepinephrine reuptake inhibitor (SNRI), while the addition of magnesium is intended to potentially enhance analgesic efficacy or mitigate side effects, possibly through NMDA receptor modulation. The product is currently in the certification and market authorization phase, following clinical development for pain management.

Brand names
TraMag
Other names
tramadol plus magnesium combination
02

Targets

NET (Norepinephrine Transporter)NMDAR (Glutamate receptor ionotropic, NMDA)MOR (Mu opioid receptor)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on TraMag.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TraMag.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call